Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Home intravenous antibiotic therapy programme, 1999.

D Steinmetz1, E Berkovits, H Edelstein

  • 1Hospital-at-Home Department, Health Continuation Management Unit, Clalit Health Services, Haifa and Western Galilee District, Israel.

The Journal of Infection
|September 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Children with medical complexity: a scoping review of interventions to support caregiver stress.

Child: care, health and development·2016
Same author

The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir.

HIV medicine·2015
Same author

Chromosome localization and characterization of a family of long interspersed repetitive DNA elements from the genus Zea.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Bacteriological aspects of Darier's disease.

Journal of the European Academy of Dermatology and Venereology : JEADV·2012
Same author

Risk factors for non-Escherichia coli community-acquired bacteriuria.

Infection·2012
Same author

Trends in outpatient antibiotic use in Israel during the years 2000-2010: setting targets for an intervention.

Infection·2012

Home Intravenous Antibiotic Therapy (HIAT) is a safe and effective treatment option. This program significantly reduced healthcare costs while providing comfortable care for patients.

Area of Science:

  • Infectious Diseases
  • Health Economics
  • Pharmacology

Background:

  • Home Intravenous Antibiotic Therapy (HIAT) offers an alternative to inpatient care.
  • Evaluating HIAT programs is crucial for optimizing resource allocation and patient outcomes.

Purpose of the Study:

  • To assess the cost-effectiveness of the HIAT program in Northern Israel.
  • To evaluate the safety and patient comfort associated with HIAT.

Main Methods:

  • Retrospective review of medical records for patients receiving HIAT in 1999.
  • Analysis of clinical diagnoses, pathogens, antibiotics used, complications, and cost savings.

Main Results:

  • 284 HIAT courses were administered to 250 patients, with soft-tissue infections and osteomyelitis being common diagnoses.

Related Experiment Videos

  • Pseudomonas aeruginosa was the most frequent pathogen, and Ceftazidine the most prescribed antibiotic.
  • The HIAT program resulted in significant cost savings of $815,000 with only minor complications reported.

    • Conclusions:

    • HIAT is an effective and safe treatment modality.
    • The program demonstrates significant economic benefits and enhances patient comfort.
    • HIAT represents a valuable healthcare strategy with a positive financial impact.